Table 2 |
||
|
outcomes on ART for adults |
||
| N |
Result |
|
|
|
||
| Probabilities of survival1 (95%CI) |
||
| at 6 months |
129 |
0.94 [0.89–0.96] |
| at 1 year |
70 |
0.89 [0.82–0.93] |
| New WHO clinical stage 3 or 4 events n (%) |
||
| between 0 and 12 months |
222 |
72 (32.4%) |
| between 1 & 2 years |
70 |
10 (14.3%) |
| Median CD4 (in cells/mm3) |
||
| at 6 months |
53 |
205.0 |
| at 1 year |
29 |
202.0 |
| Median CD4 gain (in cells/mm3) |
||
| at 6 months |
32 |
91.0 |
| at 1 year |
25 |
104.0 |
| BMI < 17 n (%) |
||
| at 6 months |
105 |
14 (13.3%) |
| at 1 year |
52 |
6 (11.5%) |
|
1 Combined endpoint of those not dead or lost to follow-up | ||
O'Brien et al. Conflict and Health 2009 3:1 doi:10.1186/1752-1505-3-1 |
||
